Sheena K. Aurora, MD

VP, Medical Affairs
Impel Pharmaceuticals
Seattle, Washington

Disclosure information not submitted.

Presentation(s):

• Assessment of the Potential for Drug–Drug Interactions Between INP104 (Trudhesa®) and Gepants for Migraine Management Using a Model-based Approach

  POSTER ABSTRACT

• Real-world assessment of concomitant migraine medication use in patients using INP104 (Trudhesa®) in the United States

  POSTER ABSTRACT